Loading company…
Riskpilot
← Back to search
Sign in
Get full access
ALVIRAL AS
AS
In liquidation
Org 930042692
Pløens gate 7, 0181 Oslo
Research and experimental development on natural sciences and engineering · NACE 7210
Est. 2022
1 employees
Watchlist
Share
Overview
Financials
People & ownership
Related companies
Revenue 2024
NOK 0
EBITDA margin
—
+42% vs 2023
Equity ratio
-6090.4%
Financial strength
Net profit 2024
NOK -666K
+43% vs 2023
EBITDA — year on year
NOK millions
0M
-0M
-1M
-1M
-1M
0M
2022
-1M
-100%
2023
-1M
0%
2024
Key figures
Annual report 2024
Revenue
NOK 0
—
EBITDA
NOK -666K
+42%
Net profit
NOK -666K
+43%
Total assets
NOK 32K
-80%
Equity
NOK -2M
-51%
Employees
1
—
Company information
Legal name
ALVIRAL AS
Org number
930042692
Legal form
Aksjeselskap
NACE code
7210 · Research and experimental development on natural sciences and engineering
Founded
17. oktober 2022
Share capital
NOK 30 000
Employees
1 (FTE)
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Daglig leder eller styrets leder hver for seg.
Company purpose
Utvikling av virusbasert immunterapi.
Contact
Address
Pløens gate 7, 0181 Oslo
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Research and experimental development on natural sciences and engineering
Companies in Oslo
All Norway companies
Revenue
NOK millions
0M
0M
1M
1M
1M
0M
2022
0M
2023
0M
2024
EBITDA
NOK millions
0M
0M
1M
1M
1M
0M
2022
-1M
2023
-1M
2024
Income statement
NOK thousands
Item
2022
2023
2024
Revenue
0
0
0
Staff expenses
−0
−1 066
−479
EBITDA
−163
−1 153
−666
Depreciation & amort.
−0
−0
−0
EBIT
−163
−1 153
−666
Net financials
0
−5
−0
Profit before tax
−163
−1 158
−666
Tax
−0
−0
−0
Net profit
−163
−1 158
−666
Balance sheet
NOK thousands
Item
2022
2023
2024
Total assets
23
160
32
Equity
−139
−1 297
−1 963
Long-term debt
0
0
0
Short-term debt
161
1 457
1 995
Total debt
161
1 457
1 995
Financial ratios
5-year trend
EBITDA margin
-66552600.0%
This company
15.8%
Market median
-421219087% vs market
2022
2024
Equity ratio
-6090.4%
This company
38.2%
Market median
-16043% vs market
2022
2024
Return on equity
-66598200.0%
This company
18.4%
Market median
-361946839% vs market
2022
2024
Net profit margin
-66598200.0%
This company
8.1%
Market median
-822200100% vs market
2022
2024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
2022
2024
Debt / equity
1.02×
This company
0.62×
Market median
-65% vs market
2022
2024
Annual reports & filings
Annual report 2024
Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
View
PDF
Management
Actively employed in the business
Name
Role
Member since
Current (1)
CJ
Christoffer James Falchenberg
Chief Executive Officer
Chief Executive Officer
2022
Board of directors
Non-executive oversight
Name
Role
Member since
Current (1)
MS
Marcus Sahlin Pettersen
Chairman
2022
Shareholders
As of last annual report
Shareholder
Type
Ownership
Votes
Since
Alv B As
Company
100%
100%
2022
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
Jajim As
Alv As
Alv B As
ALVIRAL AS
(this company)
Board network connections
Board members of ALVIRAL AS also hold positions in
0
other companies.
Person
Role here
Other companies
Christoffer James Falchenberg
Chief Executive Officer
0 companies
Marcus Sahlin Pettersen
Chairman
0 companies